[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 604
Citations 0
Comment & Response
June 2016

American Academy of Neurology Guidelines and the Neurologic Determination of Death

Author Affiliations
  • 1Department of Critical Care, Mayo Clinic Hospital, Phoenix, Arizona
  • 2Department of Physical Medicine and Rehabilitation, Mayo Clinic, Scottsdale, Arizona
JAMA Neurol. 2016;73(6):760-761. doi:10.1001/jamaneurol.2016.0428

To the Editor Greer et al1 analyzed compliance of hospital protocols on brain death (BD) determination with the 2010 American Academy of Neurology (AAN) guidelines. They posited that this neurologic standard is 100% accurate. We comment on the accuracy claim.

First, accuracy is judged by resumption of a specific set of ceased neurologic functions within a predefined short timeline. Longer waiting times negatively affect organ donation. However, the irreversibility timeline of BD findings has not been scientifically established. The eventual outcome is terminal organ procurement or treatment withdrawal, but, although resulting in a 100% death rate, inherently confounds the reported accuracy or false-positive rate. Indeed, false-positive cases are generally reported when court orders support families’ request for prolonged life-support treatment. The McMath2 and Hailu3 cases are examples.

First Page Preview View Large
First page PDF preview
First page PDF preview
×